Analysis of the Pparg promoter in plasma cell-free DNA has identified differential DNA methylation patterns in specific CpGs that distinguish between mild and severe fibrosis in NAFLD patients [127]. Here, PPARG is linked to metabolic dysfunction-associated steatotic liver disease.